Related Experiment Videos
[Limulus amebocyte lysate assay for diagnosing intraamniotic infection]
M Mazor1, A Wiznitzer, W Chaim
1Division of Obstetrics and Gynecology, Soroka Medical Center of Kupat Holim.
Insights
The Limulus amebocyte lysate (LAL) assay is a valuable tool for diagnosing intraamniotic infection in women experiencing preterm labor. This rapid test demonstrates high sensitivity and specificity, aiding in timely clinical decisions.
Area of Science:
- Obstetrics and Gynecology
- Infectious Diseases
- Diagnostic Microbiology
Context:
- Intraamniotic infection (IAI) is a significant complication in preterm labor.
- Accurate and timely diagnosis of IAI is crucial for maternal and fetal outcomes.
- Transabdominal amniocentesis is a method for obtaining amniotic fluid for diagnostic testing.
Purpose:
- To evaluate the diagnostic performance of the Limulus amebocyte lysate (LAL) assay for intraamniotic infection.
- To assess the LAL assay's ability to predict premature delivery in women with preterm labor.
Summary:
- The study assessed the Limulus amebocyte lysate (LAL) assay in 51 women with preterm labor and intact membranes.
- The LAL assay showed high sensitivity (81.8%) and specificity (97.5%) for detecting intraamniotic infection.
- The assay also demonstrated utility in predicting premature delivery, with a specificity of 90.9%.
Impact:
- The Limulus amebocyte lysate (LAL) assay offers a simple, rapid, and sensitive method for diagnosing intraamniotic infection.
- This diagnostic capability can potentially improve management strategies for preterm labor.
- Early detection of IAI using LAL may lead to better clinical outcomes for mothers and neonates.
Abstract:
The value of the Limulus amebocyte lysate assay (LAL) in the diagnosis of intraamniotic infection was determined in amniotic fluid from transabdominal amniocenteses in 51 women in preterm labor with intact membranes. The prevalence of positive amniotic fluid cultures was 21.5% (11/51) in detecting intraamniotic infection. The LAL was positive in 19.6% (10/51), its sensitivity 81.8% (9/11), specificity 97.5% (39/40), positive predictive value 90.0% (9/10), and negative predictive value 95.1% (39/41). Similarly, in detecting women who would fail tocolysis and deliver prematurely, its sensitivity was 27.6% (8/29), specificity 90.9% (20/22), positive predictive value 80% (8/10), and negative predictive value 48.8% (20/41). We conclude that LAL is a simple, rapid and sensitive test for detecting intraamniotic infection in women in preterm labor.